Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Depreciation & Amortization (CF): 2021-2022

Historic Depreciation & Amortization (CF) for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $25,582.

  • Cardiol Therapeutics' Depreciation & Amortization (CF) fell 6.60% to $25,582 in Q3 2022 from the same period last year, while for Sep 2022 it was $111,067, marking a year-over-year change of. This contributed to the annual value of $118,877 for FY2024, which is 2.15% down from last year.
  • As of Q3 2022, Cardiol Therapeutics' Depreciation & Amortization (CF) stood at $25,582, which was down 0.16% from $25,623 recorded in Q2 2022.
  • Cardiol Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $33,509 for Q2 2021, and its period low was $25,582 during Q3 2022.
  • Over the past 2 years, Cardiol Therapeutics' median Depreciation & Amortization (CF) value was $27,353 (recorded in 2021), while the average stood at $28,349.
  • Over the last 5 years, Cardiol Therapeutics' Depreciation & Amortization (CF) had its largest YoY gain of 22.79% in 2022, and its largest YoY loss of 23.53% in 2022.
  • Quarterly analysis of 2 years shows Cardiol Therapeutics' Depreciation & Amortization (CF) stood at $27,353 in 2021, then declined by 6.60% to $25,582 in 2022.
  • Its last three reported values are $25,582 in Q3 2022, $25,623 for Q2 2022, and $32,509 during Q1 2022.